Both in Pharmaceuticals
Dyne Therapeutics vs Amylyx Pharmaceuticals
Over the past year DYN returned −13.0% and AMLX returned +76.2%; their daily moves had a correlation of 0.32.
DYN −13.0% AMLX +76.2%Growth of $1, one year, split-adjusted
| Metric | DYN | AMLX |
|---|---|---|
| Price | $14.25 | $26.34 |
| Market cap | $2.66B | $3.31B |
| Today | −6.80% | −4.74% |
| 1 month | −21.1% | −22.4% |
| 6 months | −30.2% | +43.5% |
| Year to date | −27.1% | +118.0% |
| 1 year | −13.8% | +66.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $685.0M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 54.2% | 115.3% |
| Short % of float | 14.9% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).